Via @BusinessNewsAus #Australia's top 20 #cannabis companies $NTI.AX studying paediatric #ASD for #NTI164 in collab with Monash Children’s Hospital. NTI164 combines several ‘minor’ #cannabinoids to create an ‘entourage effect’ shown to be more potent. bit.ly/3NGzoQG

Two very different approaches to fire management in the NT On your left, mostly Indigenous rangers in Arnhem Land conducting mosaic early season burns🔥 On your right, the Australian Defence Force 🔥

via Stockhead $NTI.AX says its #cannabis strain works well when combined with #Diclofenac Significant development in preclinical research of lead asset program NTI164, a strain containing high levels of unique minor cannabinoids & less than 0.3% THC. bit.ly/3mvAALn

Great presentation and very positive results! $NTI $NTI.AX

#ASXNews Q&A on NTI164 Breakthrough Clinical Trial Results in #ASD Following numerous shareholder questions & enquiries, $NTI.AX has put together a summary of key questions & answers. Full Q&A on trial results: bit.ly/3yWG6wh Webinar Replay: bit.ly/3RVqBNK

This has to be a set play. Overload one side/corridor and attack the weak side. Whether it was planned or spontaneous I’m not sure, but it was beautiful.

micro cap believer Evan Vassos National Autistic Society Autism Awareness Aus I have to agree, $NTI $NTI.ax has the potential to trump all current #CBD stocks. Best thing is it’s not a cannabinoid stock, it’s in its own stand alone league. With potential to change lives of all ages suffering from targeted therapies. Potential is huge IMO

We spoke to Dr. Alex Andrews, CEO of Neurotech International (ASX:NTI), about the great data NTI recently received from a study of NTI164 in Autism Spectrum Disorders (ASX) and the potential of the upcoming Phase II/III trial 🧬 #stocksdownunder #sdu $nti stocksdownunder.com/video/intervie…

Gerald Quigley appeared on 6PR on Saturday Night with Tony McManus to discuss exciting new developments in Autism Spectrum Disorder (ASD) field linked to Cannabis, including a particular extract NTI164. Listen here: bit.ly/3cVE8Fg $NTI.AX #Cannabis #Autism #ASD

via The West Australian Former Perth Wildcats coach Scott Morrison opens up about son Max’s autism diagnosis Their experience highlighted the problems within the WA health system to receive an autism diagnosis. More: bit.ly/3cK4vxE $NTI.AX #Autism #ASX #Neurotech

Autism is incredibly prevalent, with one in 44 kids in the US having autism. $NTI has completed the first trial using a whole plant low THC medicinal cannabis strain to treat kids with autism as an alternative treatment. More: bit.ly/3zJlI2f #NTI #Autism #ASX

$NTI $NTI.ax 👇🏻

via POST Newspapers Cannabis extract has success in Autism Spectrum Disorder trial $NTI.AX's clinical study of NTI164 indicates it could be key to helping kids on the spectrum reach potential.

$NTI Neurotech International with Proactive at the ASX Small and Mid-Cap Conference tinyurl.com/2o9tbjku #NTI #ASX #ASXNews

A groundbreaking trial, at Monash Children's Hospital is giving hope to families of children living with autism. To learn more, Rebecca Maddern spoke with the Executive Director of Neurotech International, Dr Thomas Duthy. 7NEWS.com.au #7NEWS

Neurotech International in the media: Tonight on 7NEWS, A Melbourne mother has described the “life-changing results” from a medical trial helping her son with Autism Spectrum Disorder. #breakingnews #autism #clinicaltrials #7News youtube.com/watch?v=iL9L5I…

Check out the Neurotech International website for all the latest news and media: neurotechinternational.com/news-and-media/

Which $ASX stock would you like me to analyze? I'll pick a few and post the charts over the weekend. Like & Retweet, and your chart request will be 100% guaranteed! 🙏 Happy weekend, everyone!

“The housing market is eating the real economy”